E
E. Kowalski
Publications - 19
Citations - 141
E. Kowalski is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 19 publications receiving 141 citations.
Papers
More filters
Journal ArticleDOI
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
Jean W. Liew,Milena A. Gianfrancesco,Carly Harrison,Zara Izadi,Stephanie Rush,Saskia Lawson-Tovey,Lindsay Jacobsohn,Clairissa Ja,Kimme L. Hyrich,Laure Gossec,Anja Strangfeld,Loreto Carmona,Martin Schäfer,Elsa Frãzao-Mateus,Inita Bulina,Frances Stafford,Abdurrahman Tufan,Christine Graver,Gözde Kübra Yardımcı,J. Zepa,Samar Al Emadi,C. Cook,F. Abutiban,Dfiza Dey,Genevieve Katigbak,Lauren Kaufman,E. Kowalski,Marco Ulises Martínez-Martínez,N. Patel,Greta Reyes-Cordero,Evelyn O. Salido,Ellison Smith,David Snow,Jeffrey A. Sparks,Leanna Wise,Suleman Bhana,M. Gore-Massy,Rebecca Grainger,Jonathan S. Hausmann,Emily Sirotich,Paul Sufka,Zachary S. Wallace,Pedro Machado,Philip Robinson,Jinoos Yazdany +44 more
TL;DR: While COVID-19 vaccination prevents severe infections, poor immunogenicity in immunocompromised people threatens vaccine effectiveness and further risk mitigation strategies are likely needed to protect this selected high-risk population.
Journal ArticleDOI
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
Michael Di Iorio,C. Cook,Kathleen M M Vanni,N. Patel,Kristin M. D’Silva,X-L Fu,Jiaqi Wang,Lauren C. Prisco,E. Kowalski,Alessandra Zaccardelli,Lily W Martin,Grace Qian,Tiffany Y.T. Hsu,Zachary S. Wallace,Jeffrey A. Sparks +14 more
TL;DR: In this article , the authors examined baseline predictors of prolonged COVID-19 symptom duration (defined as lasting ≥28 days) using logistic regression and found that patients experiencing prolonged symptom duration had higher RAPID3 scores (p=0.007) and more pain (p<0.03) compared to those without prolonged symptoms.
Journal ArticleDOI
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Yumeko Kawano,N. Patel,Xiaosong Wang,C. Cook,Kathleen M M Vanni,E. Kowalski,Emily P Banasiak,Grace Qian,Michael A. DiIorio,Tiffany Y.T. Hsu,Michael E. Weinblatt,Derrick J. Todd,Zachary S. Wallace,Jeffrey A. Sparks +13 more
TL;DR: The proportion of patients with SARD with severe COVID-19 has diminished since early in the pandemic, particularly during the most recent time periods, including the initial Omicron wave.
Peer ReviewDOI
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
Grace Qian,Xiaosong Wang,N. Patel,Yumeko Kawano,X-L Fu,C. Cook,Kathleen M M Vanni,E. Kowalski,Emily P Banasiak,Katarina Bade,Shruthi Srivatsan,Zachary K Williams,Derrick J. Todd,Michael E. Weinblatt,Zachary S. Wallace,Jeffrey A. Sparks +15 more
Journal ArticleDOI